Thierry-gwenael FERRON - Soutenance en cours de traitement


Adresse Professionnelle
Departement de chirurgie oncologique INSERM CRCT 19 Institut Universitaire du Cancer - Toulouse Oncopole 1 av Joliot Curie 31059
TOULOUSE FRANCE
Identifiant ORCID 0000000285454700

Doctorat Cancérologie


Thèse soutenue le 19 juin 2015 - Université de Toulouse

Ecole doctorale : BSB - Biologie, Santé, Biotechnologies

Sujet : Modalités thérapeutiques de la carcinose péritonéale

Mots-clés de la thèse : Intraperitoneal,chimiotherapie,carcinose,pharmacocinetique,hyperthermie,

Direction de thèse : Bettina COUDERC

Co-encadrement de thèse : Jean-Pierre DELORD

Unité de recherche : ITCO - Laboratoire d'Individualisation des Traitements des Cancers Ovariens et ORL EA 4553 - TOULOUSE
Intitulé de l'équipe : Pharmacologie clinique et experimentale des medicaments anti-cancereux

Master Européen - Master 2 BTI sciences chirurgicales

obtenu en octobre 2010 - Paris XI
Option : cancerologie

Production scientifique

- Vieille P, Quenet F, Gladieff L, Rougé P, Chaltiel L, Querleu D, MD, Saint Aubert B, Martinez A, Carrere S, Ferron G. 2015. Predictive factors of acute kidney injury after cytoreduction surgery and cisplatin based hyperthermic intraperitoneal chemotherapy for ovarian peritoneal carcinomatosis: a retrospective bicentric study   European Journal of Surgical Oncology, ;,
- G. Ferron1, L. Simon1, F. Guyon2, O. Glehen3, D. Goere4, D. Elias4, M. Pocard5, L. Gladieff6, J. M. Bereder7, C. Brigand8, J. M. Classe9, J. M. Guilloit10, F. Quenet11, K. Abboud12, C. Arvieux13, C. De Chaisemartin14, D. Delroeux15, S. Durand-Fontanier16, N. Goasguen17, L. Gouthi18, B. Heyd15, R. Kianmanesh19, E. Leblanc20, V. Loi21, G. Lorimier22, F. Marchal23, P. Mariani24, C. Mariette25, P. Meeus26, S. Msika27, D. Pezet28, J. Paineau9, G. Piessen25, N. Pirro29, C. Pomel30, J. Porcheron12, G. Pourcher31, P. Ortega-Deballon32, P. Rat32, J. M. Regimbeau33, C. Sabbagh33, E. Thibaudeau9, D. Tougeron34, J. J. Tuech35, F. Zinzindohoue36, F. Herin37, L. Villeneuve L38 on behalf of the BIG-RENAPE Working Group*. 2015. Professional risks when carrying out peritoneal carcinomatosis surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): a French multicenter survey.   Annals of Oncology, ;,
- Gouy S, Ferron G, Glehen O, LeDeley MC, Marchal F, Pomel C, Quenet F, Bereder JM, Leary A, Morice P 2015. Results of a phase I dose escalation trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer   J Clinical Oncology, ;,
- Ferron G, Martinez A, Gladieff L, Mery E, David I, Delannes M, Montastruc M, Balagué G, Picaud L, Querleu D. 2014. Adherence to guidelines in gynecologic cancer surgery.   Int J Gynecol Cancer, 24(9):1675-8.,
- Picaud L, Thibault B, Mery E, Ouali M, Martinez A, Delord JP, Couderc B, Ferron G. 2014. Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose barrier on ovarian tumor progression.   J Ovarian Res. , 2014 Apr 16;7:40., http://www.ncbi.nlm.nih.gov/pubmed/24739440
- Pasquier J, Thawadi HA, Ghiabi P, Abu-Kaoud N, Maleki M, Guerrouahen BS, Vidal F, Courderc B, Ferron G, Martinez A, Al Sulaiti H, Gupta R, Rafii S, Rafii A. 2014. Microparticles mediated cross-talk between tumoral and endothelial cells promote the constitution of a pro-metastatic vascular niche through Arf6 up regulation.   Cancer Microenviron., 7(1-2):41-59. ,
- Chalret du Rieu Q, White-Koning M, Picaud L, Lochon I, Marsili S, Gladieff L, Chatelut E, Ferron G. 2014. Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia.   Cancer Chemother Pharmacol. , 74(3):571-82,
- Martinez A, Pomel C, Filleron T, De Cuypere M, Mery E, Querleu D, Gladieff L, Poilblanc M, Ferron G. 2014. Pronostic relevance of celiac lymph node involvement in ovarian cancer   Int J Gynecol Cancer, 24(1):48-53, http://www.ncbi.nlm.nih.gov/pubmed/24356411
- Le Brun JF, Ferron G, Vaysse C, Baujat M, Leguevaque P, Filleron T, Querleu D. 2013. Laparoscopic observation of the diaphragm undersurface in the staging of peritoneal carcinomatosis: comparison of three optical systems.   Eur J Obstet Gynecol Reprod Biol. , 2012 Sep;164(1):65-8., http://www.ncbi.nlm.nih.gov/pubmed/22910337
- Pomel C, Ferron G, Lorimier G, Rey A, Lhomme C, Classe JM, Bereder JM, Quenet F, Meeus P, Marchal F, Morice P, Elias D. 2010. Hyperthermic intra-peritoneal chemotherapy using Oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study.   Eur J Surg Oncol, Feb;37(2):175-80.,
- Ferron G, Martinez A, Mery E, Querleu D, Thomas F, Chatelut E, Gladieff L 2009. Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer   Bull Cancer. , 96(12):1243-52,
- Thomas F, Ferron G, Gesson-Paute A, Hristova M, Lochon I, Chatelut E. 2008. Increased tissue diffusion of oxaliplatin during laparoscopically assisted versus open heated intraoperative intraperitoneal chemotherapy (HIPEC).   Ann Surg Oncol. , Dec;15(12):3623-4., http://www.ncbi.nlm.nih.gov/pubmed/18726653
- Ferron G, Gesson-Paute A, Gladieff L, Thomas F, Chatelut E, Querleu D. 2008. Laparoscopically assisted Heated Intra-operative Intraperitoneal Chemotherapy (HIPEC): Technical aspect and pharmacokinetics data.   Humana Press - Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy, Humana Press 2008.,
- Ferron G, Dattez S, Gladieff L, Delord JP, Pierre S, Lafont T, Lochon I, Chatelut E. 2008. Pharmacokinetics of heated intraperitoneal oxaliplatin.   Cancer Chemother Pharmacol. , 62(4):679-83.,
- Gesson-Paute A, Ferron G, Thomas F, de Lara EC, Chatelut E, Querleu D. 2008. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study.   Ann Surg Oncol. , Jan;15(1):339-44. , http://www.ncbi.nlm.nih.gov/pubmed/17943387
- Ferron G, Gesson-Paute A, Classe JM, Querleu D. 2005. Feasibility of laparoscopic peritonectomy followed by intra-peritoneal chemohyperthermia: an experimental study.   Gynecologic Oncology, Nov;99(2):358-61. , http://www.ncbi.nlm.nih.gov/pubmed/16112182
Dernière mise à jour le 18 juin 2025